# Split Dose Pico-Salax + Bisacodyl vs. PEG Split Dose

> **NCT01415687** · PHASE3 · COMPLETED · sponsor: **University of Calgary** · enrollment: 171 (actual)

## Conditions studied

- Bowel Preparation for Colonoscopy

## Interventions

- **DRUG:** Polyethylene Glycol-Based Lavage
- **DRUG:** Pico-Salax (Magnesium Citrate) plus Bisacodyl

## Key facts

- **NCT ID:** NCT01415687
- **Lead sponsor:** University of Calgary
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-05
- **Primary completion:** 2011-12
- **Final completion:** 2011-12
- **Target enrollment:** 171 (ACTUAL)
- **Last updated:** 2012-05-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01415687

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01415687, "Split Dose Pico-Salax + Bisacodyl vs. PEG Split Dose". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT01415687. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*